Final Results

KRM22 PLC

22 May 2024

 

KRM22 plc
("KRM22", the "Group" and the "Company")

AUDITED RESULTS STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2023

KRM22 plc (AIM: KRM.L), the technology and software company focused on risk management in capital markets, announces its audited results for the year ended 31 December 2023 ("2023", the "Year"). 

Financial highlights

·    Annualised Recurring Revenue (ARR)^[1] as at 31 December 2023 of £5.4m (2022: £4.8m as reported, £4.6m at constant FX rate) - growth of 17.4% at constant FX rate

o  New contracted ARR in 2023 of £1.1m (2022: £1.3m)

o  Total ARR attributable to the relationship with Trading Technologies International, Inc. ("TT") of £0.4m (2022: £0.1m)

·    Total revenue recognised of £5.3m (2022: £4.3m) - growth of 23.3%

·    Adjusted EBITDA loss^[2] of £1.4m (2022: loss of £1.7m)

·    Loss before tax of £4.9m (2022: loss of £3.3m)

·    Gross cash as at 31 December 2023 of £0.9m (2022: £1.9m)

·    New £5.0m convertible loan provided by TT, of which £4.5m was drawn down in the year, to replace the previous Kestrel £3.0m convertible loan that was due to mature in September 2023

Operational highlights

·    12 new ARR contracts signed in the year including 7 new customers

·    First sales of Limits Manager product generated through the TT sales channel

·    42 institutional customers as at 31 December 2023

Post year-end events

·    Growth in ARR to £6.0m as at the date of this report

·    New Limits Manager product contract win worth £0.6m over three years with a major Futures Commission Merchant ("FCM"), one of the industry's top 15 largest FCMs

·    Group restructure and rationalisation to implement a focused cost savings programme, with annual cost savings of £1.2m

·    Board changes announced on 7 March 2024 with appointment of Dan Carter as CEO and Garry Jones as Non-Executive Chairman, replacing Stephen Casner and Keith Todd respectively, with Keith Todd remaining on the Board as Executive Director

Garry Jones, Non-Executive Chairman of KRM22, commented:

"2023 was another year of growth for KRM22, with increases in ARR and in year recognised revenue.  This momentum has continued into 2024 with further increases in ARR to £6.0m.  The product suite, team and strong pipeline of sales opportunities, together with the cost savings plan and Board changes announced in February and March 2024 respectively, mean that KRM22 has never been in a better position to deliver growth and become a cash positive business in due course."

[1] Annualised Recurring Revenue (ARR) is the value of contracted Software-as-a-Service (SaaS) revenue normalised to a one year period and excludes one-time fees.

[2] Adjusted EBITDA is the reported loss for the year, adjusted for recurring non-monetary costs including depreciation, amortisation, unrealised foreign exchange (loss)/gain and share-based payment (credit)/charges and non-recurring costs, both monetary and non-monetary, including impairment of intangible assets, profit on disposal of tangible/intangible assets and acquisition, deferred consideration write back, gain on extinguishment of debt and acquisition, funding and debt related costs.

For further information please contact:

KRM22 plc                                                                                                                                        [e-mail]

Garry Jones, Non-Executive Chairman

Dan Cater, CEO

Kim Suter, CFO

Cavendish Capital Markets Limited (Nominated Adviser and Broker)                                     [phone]

Carl Holmes / George Dollemore (Corporate Finance)

Sunila de Silva (ECM)

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.  With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018.  The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management.  The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

See more about KRM22 at KRM22.com.

CHAIRMAN'S STATEMENT

2023 was another year of growth for KRM22, with Annual Recurring Revenue ("ARR") continuing to achieve a new high of £5.4m, a 17.4% increase on 2022 at constant FX rates, as the business added more customers and further developed its broad product offering.  Twelve new ARR contracts were signed during 2023 including seven new customers.

Continued market volatility and turbulent geopolitical conditions have naturally resulted in some conservatism from companies throughout the year when assessing capital expenditure on new systems and services.  It is exactly these conditions that our risk management products are built for and can add real value, transparency and security in uncertain times.  We continue to be progressing with extensions to services for existing customers, whilst pushing hard to add new Tier one financial institutions to our customer portfolio.

Our product range of Limits Manager, Risk Manager, Market Surveillance and Risk Cockpit can be utilised individually, or in conjunction with each other, to provide a complete range of risk management services.

In March 2024, we made some internal changes and appointed Dan Carter as our new CEO.  Dan has been at KRM22 since its inception and has vast experience in the technology services industry.  I have every confidence that Dan and the management team will drive and accelerate our business to new heights.  I am also honoured to have been appointed as KRM22's chairman at the same time, and look forward to the challenges ahead.  I would like to take this opportunity to recognise Stephen Casner and Keith Todd, our predecessors as CEO and Chairman respectively, for all of their contributions to the Company since IPO just over six years ago.

The Board and I also wish to thank our loyal customers and investors for their continued commitment to our long-term vision of delivering high quality products and services to the capital markets and derivatives risk community.  The quality of our customers and their importance to the traded markets gives us much confidence that we are hitting the mark with industry professionals, who rely on KRM22's products and services to add value to their business.

I also want to congratulate the entire KRM22 team for another year of progress, and to recognise their continued hard work and loyalty to the Company.

I look forward to further growth in 2024, a continued increase in ARR, and becoming a cash generative business in due course.  KRM22 has never been in a better position as we progress through 2024 and beyond.

Garry Jones

Non-Executive Chairman

CEO'S REPORT

I am delighted to have been appointed CEO of KRM22 in March 2024.  The opportunity that KRM22 has to be the market leader of risk technology to the capital markets industry is incredibly exciting.  We have very strong foundations in place, implemented under the leadership of Keith Todd and Stephen Casner, a strong product offering and a motivated and ambitious team.  I have been at KRM22 since our inception in 2018, and in my former roles in the Sales and Customer Services teams, have seen first hand how KRM22 can satisfy our customers needs and deliver first class technology to the industry. 

Revenue growth

KRM22 continued to make great progress during 2023 with continuing growth in annualised recurring revenue ("ARR") year on year with the goal of becoming a £10.0m ARR business firmly in our sights.  The value behind the Global Risk Platform, and the ability to integrate various aspects of a firms risk is starting to be leveraged by firms.  At 31 December 2023, we had six of the top 15 Futures Commissions Merchants ("FCMs") in the world using our Limits Manager product.  The Limits Manager product has embedded itself as a true market leader and is providing firms with a much more efficient way of managing trading limits whilst at the same time giving firms a full audit of changes made.  As we progress through 2024 we anticipate the Risk Manager product to become another industry standard and achieve similar demand and success as Limits Manager has before it, allowing firms to manage and control risk in complete sync.

In 2023 we continued to grow ARR through our two distinct sales "channels" - our direct sales team as well as the product distribution agreements with various distributors including Trading Technologies International, Inc. ("TT").  KRM22 added new ARR in 2023 of £1.1m with £0.9m from direct sales and £0.2m from the TT sales channel.  The growth in ARR was primarily driven by sales of Market Surveillance (42%), Limits Manager (21%) and Risk Manager (21%), which incorporates the legacy functionality from the At-Trade P&L and Post-Trade Stress products.

The Customer Services team, made up of industry experts who have many years of experience between them, continue to ensure our service levels are of the highest quality and thus customer churn is kept to manageable levels.

The partnership with TT continues to go from strength to strength from a sales and revenue perspective.  The TT distribution agreement allows the Limits Manager product to be deployed to their customers on their platform without the timely and burdensome vendor onboarding processes that KRM22 experiences as a new vendor, thus helping to reduce the length of sales cycles.  In addition to revenue generated through the distribution agreement with TT, the partnership has also provided other revenue opportunities for KRM22 with both ARR and non-recurring revenue for specific projects, both internal and external to TT.

Products

In 2023 we simplified KRM22's product offering under the two key distinct areas of risk: Trading Risk, covering the Limits Manager and Risk Manager products, and Compliance Risk, covering the Risk Cockpit and Market Surveillance products. 

Limits Manager

Having been launched in early 2022, 2023 saw the continued development of Limits Manager with the addition of more user functionality which benefits both the execution services and risk management teams that use the product, and therefore created further operational efficiencies for those using the product.  Automation workflows have been delivered and firms are beginning to automate limit change requests that meet specific conditions when raised.  As we look ahead to 2024 we will continue to develop more reporting functions for the Limits Manager product to enhance visibility and further user understanding of what is happening with their limit change processes.

Risk Manager

When KRM22 launched in 2018, the goal and investment strategy was to bring the various aspects of risk management together in one place and 2023 saw us invest heavily in the development of Risk Manager, bringing real-time P&L, Margin, Stress scenario analysis and VaR together in one product.  The Risk Manager product also allows time series analysis of these key data points showing key trend analysis to the user when reviewing the account, or making limit change approval decisions.  We will continue to invest in the product as we migrate existing customers using the legacy At-Trade and Post-Trade products onto Risk Manager whilst also delivering the product to new customers. 

Integration of Limits Manager and Risk Manager

As we progress through 2024, KRM22 is excited to bring the integration of the Limits Manager and Risk Manager products into production.  This integration will allow risk managers the ability to review key risk metrics from Risk Manager and display it alongside the limit changes raised by a client within Limits Manager.  When the risk team within the financial institution approves the change, these values will be stored in the audit trail - a crucial view of what standing the account was in and why the decision was made at that time.  This will provide risk teams with more visibility and information in real-time when making these key decisions. 

Market Surveillance

The Market Surveillance product continues to adapt with new alerts, including Spoofing by Order Depth, Cross Trades and Gilt Closing alongside key functional changes.  We now have over 80 alert types available to customers in the application.  In 2023 KRM22 signed an agreement with TT to integrate Score, TT's AI/ML surveillance application, with KRM22's Market Surveillance product, which is a human calibrated alerting tool, to allow compliance officers to ensure their calibrations are valid.   The planned release date for this integrated product is late 2024 for TT to market and sell directly.  The project has already generated ARR and non-recurring revenue for KRM22 and the integrated product is expected to generate further revenue for KRM22 once product sales crystalise for TT though a revenue share model.

Outlook

We have continued to make good progress in the year towards our target of becoming a £10.0m ARR business with net ARR growth in 2023 of 17.4% and the addition of seven new customers using our products.  As of the date of this report, the use of the Limits Manager product by seven of the top 15 FCMs in the world demonstrates that there is demand for such product and that it, together with the Risk Manager product, has the ability to become the industry standard for FCMs.

The team is experienced, energised and ready to grow the business and improve on the results reported in 2023 as we continue the journey towards a £10.0m ARR business generating positive EBITDA and cashflows.  The pipeline of sales opportunities is strong and the reorganisation of our workforce in early 2024 will help us manage the cost base of the business as we look towards the move to positive adjusted EBITDA and cashflows.

Dan Carter

CEO

CFO'S REPORT

KRM22's financial results for the year ended 31 December 2023 has seen a continuation of the financial turnaround initially reported in the prior year, with growth of 23.3% in total revenue recognised to £5.3m from £4.3m reported for the year ended 31 December 2022. 

ARR continued to increase, with ARR exceeding £5.0m for the first time in 2023 since KRM22's inception in 2018, to end the year at £5.4m from £4.6m at 31 December 2022 at constant FX rates - a year-on-year increase of 17.4%. 

Adjusted EBITDA loss reported for 2023 was £1.4m, an improvement on the £1.7m reported in 2022.  This growth was set against continued global economic uncertainty and extended sales cycles.

Profit and Loss

Total revenue

Revenue recognised for the year to 31 December 2023 was £5.3m (2022: £4.3m), an increase of 23.3% compared with the prior year, with 90.6% (2022: 92.3%) of total revenue generated from recurring customer contracts.  Non-recurring revenue for the year ended 31 December 2023 totalled £0.5m (2022: £0.3m) and related principally to customer implementations, product development and proof of concept work.

Recurring revenue

ARR is a key metric and KPI for KRM22 and as at 31 December 2023, ARR had increased by 17.4% to £5.4m (2022: £4.8m as reported, £4.6m at constant FX rates), a net increase of £0.8m at constant FX rates (2022: net increase of £1.0m).

New contracted ARR in the year totalled £1.1m (2022: £1.3m) of which £0.6m (2022: £0.7m) was from seven new customers and £0.5m (2022: £0.6m) was generated from existing customers.  Included within the £0.6m of new ARR from new customers was £0.2m (2022: £nil) of ARR generated from sales of the Limits Manager product under the distribution agreement which KRM22 has with TT.  The £0.5m of new ARR generated from existing customers was a combination of these existing customers purchasing additional products and contractual renewals for existing products, with an increase in ARR and extensions of contractual terms.

The amount of ARR generated through partner products and services, primarily through data and news feeds, with minimal margin to KRM22, accounted for 4.6% (2022: 6.9%).

Total churn in ARR for the year was £0.4m (2022: £0.6m), from three institutional customers, of which £0.1m was anticipated as it related to a customer acquired through the acquisition of Object+ in 2019 using a bespoke product that does not form part of the current product offering.  A further £0.1m of churn was from a customer directly impacted by the SVB collapse in March 2023.  The third customer, with churn of £0.1m, related to data feeds which, whilst impacting ARR and revenue recognition, had minimal profit margin and so the effect on the operating loss is £nil. 

Gross profit

Gross profit for the year to 31 December 2023 was £4.1m (2022: £3.3m).  There was a small increase in gross profit margin to 78% compared to the prior year margin of 77% which was due to an improvement in foreign currency rates, compared with the prior year when there was volatility and adverse movements, with a significant proportion of the Group's cost of sales being Amazon Web Services server costs which are invoiced in US dollars. 

Capitalised development

A total of £1.1m (2022: £0.8m) of development was capitalised in the year to 31 December 2023.  Capitalised development is amortised over three years.

Adjusted EBITDA

Adjusted EBITDA is the key metric that the Company considers in order to understand the cash-profitability of the business.  This is due in particular to the non-cash items that impact the Income Statement under IFRS accounting, such as non-cash share-based payment charges.

Adjusted EBITDA for the year to 31 December 2023 was a £1.4m loss (2022: loss of £1.7m).  Whilst the adjusted EBITDA loss reported for the year is a £0.3m improvement on the prior year, this reduction is not proportional to the increase in total revenue recognised in the year compared with the prior year and this was due to the increase in administrative expenses. 

The increase in administrative costs was primarily driven by two factors.  Firstly, in 2022 KRM22 used the investment proceeds from TT's investment in KRM22 in December 2021 to invest in Revenue, Customer Services and Development resource to help drive the business forward and the timing of this new resource joining KRM22 occurred throughout 2022.  Administrative costs for the year ended 31 December 2023 therefore includes a full year of increased staff costs compared with the prior year.  In addition to the aforementioned investment in resource, the rate of inflation in 2022 and 2023 meant that staff salary reviews, which are completed on an annual basis in the first quarter of each year, resulted in a significantly higher average pay increase in 2023 compared to 2022.  The average pay increase in 2023, whilst being higher than 2022, was not matched to the rate of inflation.

A reconciliation of Adjusted EBITDA loss to the reported operating loss is provided as follows:

	2023 £'m	2022 £'m
Adjusted EBITDA loss	(1.4)	(1.7)
Depreciation and amortisation	(1.3)	(1.6)
Impairment of intangible assets	(1.6)	-
Unrealised FX (losses)/gain	(0.5)	0.8
Deferred consideration write back	0.1	-
Acquisition and debt expenses	0.0	-
Gain on extinguishment of debt	0.1	-
Shared-based payment (credit)/expense	0.1	(0.1)
Operating loss	(4.5)	(2.6)

Operating loss

Reported operating loss for the year to 31 December 2023 was £4.5m (2022: loss of £2.6m) and includes an impairment charge of £1.6m primarily related to a revision in the estimated recoverable amount of goodwill using a value-in-use model by projecting cashflows for future years using different inputs to the model compared with prior years.

Finance charges

Net finance expense in the year was £0.4m (2022: £0.6m) and includes:

·    Loan interest of £0.4m (2022: £0.3m);

·    IFRS16 lease liability interest of £0.0m (2022: £0.1m); and

·    Derivative financial instrument fair value adjustment of £0.0m (2022: £0.2m).

Taxation

The tax credit in the year was £0.3m (2022: credit of £0.2m) which includes a £0.2m (2022: £0.1m) R&D tax credit received. 

Financial position

Assets

The cash balance as at 31 December 2023 was £0.9m (2022: £1.9m).

Current assets at 31 December 2023 include trade and other receivables of £1.1m (2022: £1.5m). 

Non-current assets were £5.8m (2022: £7.8m) relating principally to: £4.2m for goodwill and assets acquired (2022: £6.1m), £1.4m (2022: £1.3m) for capitalised development costs, and £0.1m for right of use assets recognised under IFRS16 (2022: £0.4m).

Liabilities

As at 31 December 2023, our principal liabilities were:

·    £4.5m convertible loan owed to TT plus accrued interest of £0.2m.

·    £0.7m (US$0.9m) deferred consideration for earn out payments for the acquisition of Object+.  The deferred consideration can be satisfied in either cash or Company Ordinary Shares in KRM22 at the Company's discretion.

·    £0.4m for the right of use assets relating to all future payments of leased-office rentals under IFRS16 'Leases' whereby such lease payments are provided for at today's value.  KRM22 has one remaining lease in London which expires in 2024.

·    £2.2m of deferred revenue; contracted and paid services that will be released in a future period.

Investors

As an AIM quoted business, a large proportion of KRM22's shareholders are professional investment funds.  In addition, the Directors together owned 3,764,958 shares at the year end, representing 10.6% of the Company's issued share capital.

Funding

On 17 June 2023, KRM22 entered into an agreement for a new three year £5.0m convertible loan facility (the "TT Convertible Loan") with TT, the Company's largest shareholder.  At 31 December 2023, KRM22 had drawn down £4.5m of the total facility amount and these proceeds were used to replace the Company's existing convertible loan (the "Kestrel Convertible Loan") with Kestrel Partners LLP.  The outstanding balance of the Kestrel Convertible Loan, inclusive of principal and accrued interest was £3.1m.

The interest rate payable on the TT Convertible Loan is the average 90 day Secured Overnight Financing Rate ("SOFR") and a margin of 5.5%, subject to a minimum aggregate percentage rate per annum of 9.25%.  Interest is payable quarterly in arrears however KRM22 has the ability to defer interest payments in the initial 18 months (the "Initial Interest Period"), with the total deferred interest in the Initial Interest Period being paid in two equal instalments on the calendar quarters ending after the 18^th and 21^st month anniversary of the facility, i.e. 31 December 2024 and 31 March 2025. 

Under the terms of the TT Convertible Loan agreement dated 17 June 2023 (the "TT Loan Agreement"), any amounts drawn down from the TT Convertible Loan could be converted into new Ordinary Shares in the Company by TT at any time at the lowest conversion price of: £0.46, the volume weighted average price of the Company's ordinary shares for the three month period prior to service of conversion notice; or the lowest daily closing price for the 30 completed calendar days prior to service of conversion notice.  On 1 July 2023, the TT Loan Agreement was amended to remove the variability of the conversion price and replace with a fixed conversion price of £0.46.  TT has the right to prevent any conversion which would trigger a Rule 9 event under the Takeover Code.

The TT Convertible Loan is secured on certain KRM22 assets and includes covenants based on the Group's financial performance including ARR, revenue recognition and solvency.

Use of cash in the year

Our net cash outflow in the year was £1.0m, which included £4.5m draw down receipts from the TT Convertible Loan, of which £3.0m was used to settle the Kestrel Convertible Loan principal, £1.1m was used for capitalised development, £0.2m was used to pay interest on the Kestrel Convertible Loan and the balance was used to provide working capital for KRM22.

Going concern

The financial statements have been prepared on a going concern basis based on a range of cashflow forecasts and scenarios covering a period of at least twelve months from the date of this report.  The time to close new customers and the value of each customer, which are deemed individually as high value and low volume in nature, is key to the forecast being achieved.  Even if the forecast is achieved, there remains a material uncertainty around KRM22 operating within the financial covenants associated with the TT Convertible Loan.  The Board have received a letter of support from TT that they would be willing to enter into discussions with KRM22 around amending the terms of the TT Convertible Loan to ensure that KRM22 does not breach the financial covenants.  Further analysis of KRM22's going concern position is detailed in note 2 (notes to the financial information).

Shareholdings and Earnings per share

As at 31 December 2023, KRM22 had 35,666,336 shares in issue and this was also the undiluted weighted average number of shares for the period.  The resulting Earning per Share ("EPS") is a 13.0p loss per share (2022: loss of 8.7p).  Due to the loss made by the Company in the year, the diluted EPS is the same as EPS.

Conclusion

In 2023, KRM22 has continued to grow with recognised revenue increasing by 23.3% to £5.3m, ARR increasing to £5.4m which, as at the date of this report, has further increased to £6.0m.  Whilst administrative costs increased in 2023 compared with the prior year, the Board took action in early 2024 to review the underlying cost base of the business and have since implemented a focused cost savings programme to generate annual cost savings of approximately £1.2m.  This cost savings programme, together with significant sales pipeline opportunities, both from direct selling opportunities and through the TT distribution agreement, will improve the adjusted EBITDA position going forward and accelerate the Company's path to profitability.

Kim Suter

CFO

Consolidated income statement and statement of comprehensive income

for the year ended 31 December 2023

	Note	2023 £'000	2022 £'000
Revenue Cost of sales	3	5,266 (1,145)	4,273 (955)
Gross profit Other operating income Administrative expenses		4,121 142 (8,788)	3,318 131 (6,077)
Operating loss before interest, taxation, depreciation, amortisation, share based payment and exceptional items ('Adjusted EBITDA')		(1,399)	(1,684)
Depreciation and amortisation		(1,298)	(1,637)
Impairment of intangible assets		(1,593)	-
Profit on disposal of tangible/intangible assets		-	14
Deferred consideration write back		115	-
Gain on extinguishment of debt (net)		127	-
Unrealised foreign exchange (loss)/gain		(539)	812
Acquisition, funding and debt related expenses		(38)	-
Share based payment credit/(charge)		100	(133)
Operating loss		(4,525)	(2,628)
Finance charge (net)		(353)	(641)
Loss before taxation		(4,878)	(3,269)
Taxation credit		259	168
Loss for the year		(4,619)	(3,101)
Loss for the year attributable to:
Equity shareholders of the parent		(4,619)	(3,101)
		(4,619)	(3,101)
Other comprehensive income Item that may be reclassified subsequently to profit and loss:
Exchange gain/(loss) on translation of foreign operations		334	(563)
Total comprehensive loss for the year		(4,285)	(3,664)
Total comprehensive loss for the year attributable to:
Equity shareholders of the parent		(4,285)	(3,664)
		(4,285)	(3,664)
Loss per ordinary share
Basic losses per share	4	(13.0p)	(8.7p)
Diluted losses per share	4	(13.0p)	(8.7p)

Consolidated statement of financial position

at 31 December 2023

	Note	2023 £'000	2022 £'000
Non-current assets
Goodwill	5	3,516	5,167
Other intangible assets	5	2,105	2,244
Property, plant and equipment		21	11
Right of use assets		136	369
		5,778	7,791
Current assets
Trade and other receivables		1,142	1,462
Cash and cash equivalents		886	1,900
		2,028	3,362
Total assets		7,806	11,153
Current liabilities
Trade and other payables		3,900	3,853
Lease liabilities		369	493
Loans and borrowings		391	2,974
Derivative financial liability		196	255
		4,856	7,575
Net current liabilities		(2,828)	(4,213)
Non-current liabilities
Trade and other payables		-	30
Lease liabilities		-	122
Loans and borrowings		3,887	-
Deferred tax liability		164	245
		4,051	397
Total liabilities		8,907	7,972
Net (liabilities)/assets		(1,101)	3,181
Equity
Share capital		3,567	3,567
Share premium		20,517	20,517
Merger reserve		(190)	(190)
Convertible debt reserve		327	224
Foreign exchange reserve		(114)	(448)
Share-based payment reserve		2,945	3,045
Retained deficit		(28,153)	(23,534)
Total equity		1,101	3,181

Consolidated statement of cash flows

for the year ended 31 December 2023

	2023 £'000	2022 £'000
Cash flows from operating activities
Loss for the year	(4,619)	(3,101)
Adjustments for:
Tax credit	(259)	(168)
Net finance expense	353	641
Amortisation of intangible assets	1,059	1,324
Depreciation of property, plant and equipment and right of use assets	239	313
Impairment of intangible assets	1,593	-
Profit on disposal of intangible/tangible assets	-	(14)
Deferred consideration write back	(115)	-
Gain on extinguishment of debt	(127)	-
Unrealised loss/(gain) on non-GBP denominated loans	539	(812)
Equity-settled Share-based payment (credit)/expense	(100)	133
Income taxes received	186	97
	(1,251)	(1,587)
Decrease/(increase) in trade and other receivables	320	(721)
Increase in trade and other payables	52	187
Net cash flows used in operating activities	(879)	(2,121)
Cash flows from investing activities
Acquisition deferred consideration payment	(43)	-
Purchase of intangible assets	(1,105)	(840)
Purchase of property, plant and equipment	(16)	(8)
Net cash used in investing activities	(1,164)	(848)
Cash flows from financing activities
Lease payments principal	(232)	(217)
Lease payments interest	(18)	(33)
Receipts from borrowings	4,500	-
Interest paid	(208)	(285)
Repayments of borrowings	(3,000)	-
Net cash from/(used in) financing activities	1,042	(535)
Net decrease in cash and cash equivalents	(1,001)	(3,504)
Cash and cash equivalents at beginning of year	1,900	5,362
Effect of foreign exchange rate changes	(13)	42
Cash and cash equivalents at end of year	886	1,900

Consolidated statement of changes in equity

for the year ended 31 December 2023

	Ordinary shares	Share premium	Merger reserve	Convertible debt reserve	Foreign exchange reserve	Share based payment reserve	Retained losses	Total equity
	£'000	£'000	£'000	£'000	£'000	£'000	£'000	£'000
At 1 January 2022	3,567	20,517	(190)	224	115	2,912	(20,433)	6,712
Loss for the year	-	-	-	-	-	-	(3,101)	(3,101)
Other comprehensive loss	-	-	-	-	(563)	-	-	(563)
Total comprehensive loss	-	-	-	-	(563)	-	(3,101)	(3,664)
Share-based payments	-	-	-	-	-	133	-	133
At 31 December 2022	3,567	20,517	(190)	224	(448)	3,045	(23,534)	3,181
Loss for the year	-	-	-	-	-	-	(4,619)	(4,619)
Other comprehensive gain	-	-	-	-	334	-	-	334
Total comprehensive gain/(loss)	-	-	-	-	334	-	(4,619)	(4,285)
Convertible debt option	-	-	-	103	-	-	-	103
Share-based payments	-	-	-	-	-	(100)	-	(100)
At 31 December 2023	3,567	20,517	(190)	327	(114)	2,945	(28,153)	(1,101)

Notes to the financial information

1.       Accounting basis

The financial information set out in this document does not constitute the Group's statutory accounts for the years ended 31 December 2022 or 2023.  Statutory accounts for the years ended 31 December 2022 and 31 December 2023, which were approved by the Directors on 21 May 2024, have been reported on by the Independent Auditors.  The Independent Auditor's Reports on the Annual Report and Financial Statements for each of 2022 and 2023 were unqualified, did draw attention to a matter by way of emphasis, being going concern and did not contain a statement under 498(2) or 498(3) of the Companies Act 2006.

Statutory accounts for the year ended 31 December 2022 have been filed with the Registrar of Companies.  The statutory accounts for the year ended 31 December 2023 will be delivered to the Registrar of Companies in due course and will be posted to shareholders shortly, and thereafter will be available from the Company's registered office at 5 Ireland Yard, London, England, EC4V 5EH and from the Company's website: http://krm22.com/investors/

The financial information set out in these results has been prepared using the recognition and measurement principles of International Accounting Standards, International Financial Reporting Standards and Interpretations in conformity with the requirements of the Companies Act 2006.  The accounting policies adopted in these results have been consistently applied to all the years presented and are consistent with the policies used in the preparation of the financial statements for the year ended 31 December 2023, except for those that relate to new standards and interpretations effective for the first time for periods beginning on (or after) 1 January 2022.  There are deemed to be no new standards, amendments and interpretations to existing standards, which have been adopted by the Group, that have had a material impact on the financial statements.

The Group's financial information has been presented in Pounds Sterling (GBP).  Amounts are rounded to the nearest thousand, unless otherwise stated.

2.       Going concern

These financial statements have been prepared on the going concern basis.  The Directors have reviewed KRM22's going concern position taking into account of its current business activities, budgeted performance and the factors likely to affect its future development, which are set out in this Annual Report, and include KRM22's objectives, policies and processes for managing its capital, its financial risk management objectives and its exposure to credit and liquidity risks.

The Directors have undertaken a significant assessment of the cashflow forecast covering a period of at least twelve months from the date of approval of the financial statements.  Cashflow forecasts have been prepared based on a range of scenarios including, but not limited to, existing customer churn at different churn rates, no new contracted sales revenue, delayed sales and a combination of these different scenarios.

Having assessed the sensitivity analysis on cashflows, the key risks to KRM22 remaining a going concern and not being in breach of the financial covenants associated with the TT Convertible Loan is existing customers paying on payment terms and within 45 days of invoice, customer churn or up to 10%, conversion of some of the sales opportunities that are currently at contract negotiation stage and maintaining control of the cost base.

The time to close new customers and the value of each customer, which are deemed individually as high value and low volume in nature, is key to the forecast being achieved and KRM22 continuing to operate within its existing facilities, this being KRM22's current cash balance and the ability to drawdown on the remaining funds available through the TT Convertible Loan.  However, even if the forecast is achieved, there remains a material uncertainty around KRM22 operating within the financial covenants associated with TT Convertible Loan.  The TT Convertible Loan includes financial covenants, reported at the end of each quarter, based on the Group's financial performance and there is a risk that KRM22 breaches the Cash Covenant, which requires KRM22 to retain a minimum amount of cash, on the 31 December 2024 and 31 March 2025 measurement dates.  Failure to comply with a financial covenant will result in an Event of Default which may result in TT withdrawing the TT Convertible Loan with all accrued amounts becoming immediately due and payable which would result in KRM22 becoming insolvent. 

The Board have received a letter of support from TT that they would be willing to enter into discussions with KRM22 around amending the terms of the TT Convertible Loan to ensure that KRM22 does not breach the Cash Covenant.  Amendments could include, but are not limited to, reducing the value of the Cash Covenant at each measurement date so that KRM22's cash exceeds the minimum cash requirement on each measurement date, and deferring the accrued interest payments that are due on 31 December 2024 and 31 March 2025 to 30 June 2025 and 30 September 2025 respectively.  If the TT Convertible Loan was not amened, KRM22 would be obliged to seek alternative resolution including implementing extensive cost reduction measures.

The Directors have concluded that the circumstances set forth above indicates the existence of a material uncertainty that may cast significant doubt on KRM22's ability to continue as a going concern.  However, given KRM22's forecast, visible sales pipeline, working capital needs and letter of support from TT, the Directors have considered it appropriate to prepare the financial statements on a going concern basis and the financial statements do not include the adjustments that would be required if KRM22 were unable to continue as a going concern.

3.       Segmental reporting

The Board of Directors, as the chief operating decision maker in accordance with IFRS 8 Operating Segments, has determined that KRM22 have identified two areas of risk management as operating segments, together with a third segment where the two areas of risk management are not easily separable, however for reporting purposes into a single global business unit and operates as a single operating segment, as the nature of services delivered are common.

The internal management accounting information has been prepared in accordance with IFRS but has a non-GAAP 'Adjusted EBITDA' as a profit measure for the overall group.  This amount is reported on the face of the income statement.

KRM22's revenue from external customers and information about its non-current assets, excluding deferred tax, by geography is detailed below:

		Revenue 2023	Non-current assets 2023	Revenue 2022	Non-current assets 2022
		£'000	£'000	£'000	£'000
	UK	1,906	2,109	1,712	2,694
	Europe	792	1,466	716	1,955
	USA	2,215	2,203	1,520	3,141
	Rest of world	353	-	325	1
	Total	5,266	5,778	4,273	7,791

The Directors consider that the business has two areas of risk management: Trading Risk and Corporate Risk as is described in the Strategic Report.  Within these segments, there are two revenue streams with different characteristics, which are generated from the same assets and cost base.

For the year ended 31 December 2023, no customer generated more than 10% of total revenue recognised in the year.  For the year ended 31 December 2022, one customer, reported within the UK segment, generated more than 10% of total revenue and the total revenue received from this customer was £0.5m.

Non-current assets include goodwill and intangible assets recognised on consolidation and are classified by reference to the geographical location of the KRM22 group company which initially acquired the acquiree.

Recurring revenue is recognised over the period of time and non-recurring revenue is recognised at a point in time.

		2023	2022
		£'000	£'000
	Recurring revenue	4,769	3,945
	Non-recurring revenue	497	328
	Total revenue	5,266	4,273

		2023	2022	2020
		£'000	£'000	£'000
	Trading Risk	2,487	1,867	420
	Corporate Risk	2,593	2,258	2,476
	Multiple Risk	72	148
	TT platform	114	-	1,673
	Total	5,266	4,273	4,594

4.       Loss per share

Basic earnings per share is calculated by dividing the loss attributable to the equity holders of KRM22 by the weighted average number of shares in issue during the year.

KRM22 has dilutive ordinary shares, this being warrants, restricted stock awards and share options granted to employees.  As KRM22 has incurred a loss in the year, the diluted loss per share is the same as the basic earnings per share as the loss has an anti-dilutive effect.

		2023	2022
		£'000	£'000
	Loss for the year attributable to equity holders of the parent	(4,619)	(3,101)
	Basic weighted average number of shares in issue	35,666,336	35,666,336
	Diluted weighted average number of shares in issue	46,492,491	46,671,529
	Basic and diluted loss per share	(13.0p)	(8.7p)

5.       Intangible assets

		Goodwill on consolidation £'000	Acquired software & related assets £'000	Capitalised development costs £'000	Total £'000
Cost
At 1 January 2023		8,053	2,944	3,564	14,561
Additions		-	-	1,105	1,105
Foreign exchange movements		(246)	(57)	(20)	(323)
At 31 December 2023		7,807	2,887	4,649	15,343
Accumulated amortisation
At 1 January 2023		2,886	1,976	2,288	7,150
Amortisation for the year		-	228	826	1,054
Impairment charge for the year		1,497	-	96	1,593
Foreign exchange movements		(92)	19	(2)	(75)
At 31 December 2023		4,291	2,223	3,208	9,722
At 31 December 2022		5,167	968	1,276	7,411
At 31 December 2023		3,516	664	1,441	5,621

6.       Events after the reporting date

On 7 March 2024, Dan Carter was appointed CEO of the Company, whilst Stephen Casner, a founder director and former CEO of the Company, resigned from KRM22.  In addition, Keith Todd relinquished his role as Executive Chairman, whilst remaining an Executive Director of the Company and Garry Jones succeeded Keith Todd of Non-Executive Chairman of the Company.

On 10 April 2024, the Company issued 140,187 new ordinary shares of 10 pence each in the Company at a price of 85 pence per Ordinary Share as consideration for a partial settlement of the deferred consideration payable in respect of the historical acquisition of Object+ Holding B.V.

7.       Cautionary statement

This document contains certain forward-looking statements relating to KRM22.  KRM22 considers any statements that are not historical facts as "forward-looking statements".  They relate to events and trends that are subject to risk and uncertainty that may cause actual results and the financial performance of the Company to differ materially from those contained in any forward-looking statement.  These statements are made by the Directors in good faith based on information available to them and such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward-looking information.

 

END